Dynavax Technologies Corp

NASDAQ: DVAX
$11.50
+$0.29 (+2.6%)
Closing Price on September 19, 2024

DVAX Articles

ThinkstockDynavax Technologies Corp. (NASDAQ: DVAX) is feeling the wrath of the markets after an FDA panel said that there was insufficient data to support its investigational Hepatitis B drug called...
Today’s episode of the BioHealth Business Daily has many stocks moving on hepatitis news and starting with the letter “A” coincidentally.  Shares of AEterna Zentaris (NASDAQ: AEZS), Anadys...
These are this some of this Thursday’s top pre-market movers on news this morning.  A few links have been provided to show more detail and analysis over at VSInvestor.com: Dynavax Technologies...
Earnings are moving stocks, yet some are moving on other news as well in the after-hours trading session.  YUM! Brands Inc. (NYSE: YUM), United Parcel Service, Inc. (NYSE: UPS), Princeton Review...
Today’s BioHealth Business Daily is full of some of the names you might expect to see, but it also has some unusual names as well.  We are seeing share price moves in Accuray Incorporated (NASDAQ:...
Today is an unusually active day for many emerging biotech stocks in the news and we are seeing significant moves in response. We have more detail on each with appropriate links through to more...
Dynavax Technologies Corp. (NASDAQ: DVAX) is the latest biotech implosion as shares are down some 75% today.  The company gave an update on an FDA clinical hold on its investigational vaccine...
These are some of the top pre-market analyst downgrades from Wall Street this Wednesday morning: Ameriprise Financial (AMP) Cut to Market Perform at KBW. Apple (AAPL) Cut to Neutral at UBS. Dynavax...
These aren’t the only analyst calls this Monday morning, but these are the ones we are focusing on early this morning: Akamai Tech (NASDAQ: AKAM) Cut to Hold from Buy at Citigroup. American Eagle...
Xerium Technologies (XRM) delays 10-K and risk of default. Falls to $1.16 from 52-week high of $9.20. Moneygram (MGI) is taken out of one of the S&P indexes. Down to $1.62 from 52-week high of...